Cours Refocus Group, Inc. Other OTC
Actions
RFCS
US75865X2027
Recherche biotechnologique et médicale
CA 2003 | - | CA 2004 | - | Capitalisation | 2,59 M 2,36 M |
---|---|---|---|---|---|
Résultat net 2003 | -5 M -4,55 M | Résultat net 2004 | -3 M -2,73 M | VE / CA 2003 | - |
Trésorerie nette 2003 | 3 2,73 | Dette nette 2004 | 0,28 0,25 | VE / CA 2004 | - |
PER 2003 |
-1,51
x | PER 2004 |
-0,67
x | Employés | - |
Rendement 2003 * |
-
| Rendement 2004 |
-
| Flottant | 100% |
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
J. Michael Judy
CEO | Chief Executive Officer | - | 28/10/13 |
David Schanzlin
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/12 |
Selene A. Burke
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/06 |
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Director/Board Member | 76 | 01/01/11 | |
Thomas M. Loarie
CHM | Chairman | - | 01/01/14 |
Thomas Lyles
BRD | Director/Board Member | - | 01/03/05 |
Varia. 1 janv. | Capi. | |
---|---|---|
+67,53% | 63,85 Md | |
-0,77% | 41,83 Md | |
+42,38% | 40,47 Md | |
-10,02% | 27,17 Md | |
+13,30% | 26,52 Md | |
-22,79% | 18,69 Md | |
+4,70% | 12,73 Md | |
+24,10% | 12,11 Md | |
+27,41% | 12,07 Md |